A pilot, phase IIb, randomized, multi-center trial of Argatroban in combination with recombinant tissue plasminogen activator for acute stroke (ARTSS-2).

Project: Non Profit

Project Details

StatusActive
Effective start/end date11/26/14 → 11/25/39

Funding

  • U T Health Science Center at Houston